YATHARTH HOSP & TRA C S L Stock Context for AI Screening

YATHARTH HOSP & TRA C S L is a small-cap stock in Healthcare. This page summarizes key screening signals for YATHARTH HOSP & TRA C S L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive YATHARTH stock page

Price

₹810.50

1W return

-0.72%

1M return

-1.16%

3M return

+18.98%

6M return

+17.79%

1Y return

+59.19%

Market cap

₹7,809.52 cr

44.33

4.32

ROE

+14.03%

ROCE

+17.57%

RSI

51.64

Turnover

₹14.20 cr

Why it can matter in screens

Momentum: YATHARTH is above 50DMA, above 200DMA; RSI is 51.64.
Returns: 1D -0.30%, 1W -0.72%, 1M -1.16%, 3M +18.98%, 1Y +59.19%.
Trend levels: 52W high ₹862.20, 52W low ₹500.35, off high -6.00%.
Liquidity: latest turnover is ₹14.20 cr; volume vs 20D is +0.32%.
Valuation/profitability: PE 44.33, PB 4.32, ROE +14.03%, ROCE +17.57%.
Growth: 3Y sales CAGR +29.97%, 3Y profit CAGR +43.51%.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	341.56 cr	87.02 cr	47.52 cr	4.93
2025-12-31	320.47 cr	82.07 cr	45.35 cr	4.71
2025-09-30	279.42 cr	74.01 cr	41.24 cr	4.28
2025-06-30	257.77 cr	73.80 cr	42.04 cr	4.36
2025-03-31	233.03 cr	62.37 cr	38.72 cr	4.37
2024-12-31	219.16 cr	59.13 cr	n/a	nan
2024-09-30	217.77 cr	57.60 cr	n/a	3.61
2024-06-30	211.78 cr	57.32 cr	30.38 cr	3.54

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-03-31	880.49 cr	236.42 cr	130.54 cr	14.72
2024-03-31	670.55 cr	195.55 cr	114.47 cr	14.46
2023-03-31	520.29 cr	136.57 cr	65.77 cr	7.66
2022-03-31	400.94 cr	112.46 cr	44.16 cr	5.14

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	2,281.53 cr	221.10 cr	264.09 cr	1,807.16 cr
2025-09-30	1,856.28 cr	172.98 cr	26.23 cr	1,720.43 cr
2025-03-31	1,731.18 cr	204.96 cr	11.59 cr	1,637.13 cr
2025-03-31	1,731.18 cr	204.96 cr	11.59 cr	1,637.13 cr
2024-09-30	1,093.25 cr	156.07 cr	90.12 cr	932.27 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	n/a	n/a	n/a
2025-12-31	n/a	n/a	n/a
2025-09-30	n/a	n/a	n/a
2025-06-30	n/a	n/a	n/a
2025-03-31	149.60 cr	-161.23 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+55.80%	+5.25%	+12.00%	+9.37%	+26.95%	+0.00%
2025-12-31	+55.80%	+6.18%	+11.01%	+9.19%	+27.01%	+0.00%
2025-09-30	+61.64%	+6.50%	+8.70%	+7.12%	+23.16%	+0.00%
2025-06-30	+61.64%	+4.34%	+13.52%	+9.43%	+20.50%	+0.00%
2025-03-31	+61.64%	+4.45%	+13.56%	+9.42%	+20.35%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	429,121.06 cr	40.824543	+15.06%	+7.26%
DIVISLAB	DIVI S LABORATORIES LTD	174,585.42 cr	68.707369	+17.81%	+0.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	147,849.87 cr	68.354079	+29.94%	+39.35%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	119,204.71 cr	64.295958	+23.21%	+21.70%
CIPLA	CIPLA LTD	111,088.72 cr	29.624450	+12.91%	-6.65%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	108,331.15 cr	21.874917	+20.44%	+16.21%
DRREDDY	DR. REDDY S LABORATORIES	105,181.70 cr	24.542479	+13.88%	+1.20%
LUPIN	LUPIN LIMITED	103,385.66 cr	22.341869	+29.22%	+15.72%

Try these prompts

Analyze YATHARTH HOSP & TRA C S L with valuation, momentum and industry peers
Compare YATHARTH with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-06-03. Not investment advice.